Grantham, Mayo, Van Otterloo & Co (GMO)’s Brookline Bancorp BRKL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14,500
Closed -$229K 754
2022
Q1
$229K Sell
14,500
-88,491
-86% -$1.49M ﹤0.01% 664
2021
Q4
$1.67M Sell
102,991
-6,000
-6% -$95.6K 0.01% 490
2021
Q3
$1.66M Buy
108,991
+11,900
+12% +$173K 0.01% 482
2021
Q2
$1.45M Sell
97,091
-6,700
-6% -$107K 0.01% 501
2021
Q1
$1.56M Buy
103,791
+10,691
+11% +$150K 0.01% 514
2020
Q4
$1.12M Sell
93,100
-33,900
-27% -$367K 0.01% 551
2020
Q3
$1.1M Buy
127,000
+14,700
+13% +$140K 0.01% 503
2020
Q2
$1.13M Buy
112,300
+93,300
+491% +$931K 0.01% 508
2020
Q1
$214K Sell
19,000
-31,000
-62% -$442K ﹤0.01% 696
2019
Q4
$823K Sell
50,000
-80,400
-62% -$1.27M 0.01% 546
2019
Q3
$1.92M Buy
+130,400
New +$1.89M 0.01% 439

Other funds holding BRKL

Grantham, Mayo, Van Otterloo & Co (GMO)'s BRKL Position: Q2 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Brookline Bancorp (BRKL) in Q2 2022, closing a stake of 14,500 shares — an estimated $229K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BRKL in Q3 2019 and held it in 11 quarters. The position peaked at $1.92M in Q3 2019. 194 funds tracked by Wall St. Rank hold BRKL as of Q2 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Brookline Bancorp position as of Q2 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 14,500 Brookline Bancorp shares in Q2 2022, an estimated $229K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Brookline Bancorp in Q3 2019 and held it in 11 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Brookline Bancorp position peaked at $1.92M in Q3 2019.
  • 194 funds tracked by Wall St. Rank held Brookline Bancorp as of Q2 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2022, filed 12 Aug 2022.